Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Christian Angermayer · Said 5 Jun 2024 · angermayer-0184

Quote

Commitment (own venture)

“Even if the original / racemic MDMA does not recover from this setback, atai has a new, potentially better and patent-protected version of MDMA in its pipeline, which in early trials has demonstrated a much better initial safety profile.”
· Christian Angermayer on X: take on the FDA Advisory Committee vote against Lykos/MAPS MDMA therapy · tweet

He allows that racemic MDMA (the Lykos product) may not recover, and points to atai's R-MDMA as the alternative. A doubt about a further midomafetamine Phase 3 programme.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.

← Earlier · Later → · All statements